北京诺思兰德生物技术股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
3
NMPA:3
Drug Approvals
Brimonidine Tartrate Eye Drops
- Product Name
- 酒石酸溴莫尼定滴眼液
- Approval Number
- 国药准字H20243152
- Approval Date
- Sep 10, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20234037
- Approval Date
- Aug 8, 2023
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20233521
- Approval Date
- Apr 28, 2023
NMPA
Clinical Trials
No trials found
News
No news found